Zobrazeno 21 - 30
of 665
pro vyhledávání: ''
Autor:
Wenyin Shi, Ryan C Miller, Muneeb Niazi, Ayesha S Ali, Iyad Alnahhas, James J. Evans, Voichita Bar-Ad, David W. Andrews, Jon Glass, Haisong Liu, Kevin Judy, L Martinez Nina, James M. Taylor, Christopher J. Farrell
Publikováno v:
Neuro-Oncology. 23:vi45-vi46
OBJECTIVE The standard of care for the adjuvant treatment of glioblastoma is concurrent chemoradiation, maintenance temozolomide, and Tumor Treating Fields (TTFields). TTFields may reversibly impact the blood-brain barrier, most significantly at 100
Autor:
Muhammad Usman Khalid, Mohammad Hamza Bajwa, Fatima Mubarak, Noman Khan, Ahsan A. Khan, Syed Ather Enam
Publikováno v:
Neuro-Oncology. 23:vi146-vi147
INTRODUCTION Lower grade gliomas encompass grade 2 and 3 tumors. However, this term is more generalized and does not include the spectrum of radiological and tumor morphological patterns seen. Here we have established two distinct patterns of radiogr
Publikováno v:
Neuro-Oncology. 23:vi194-vi195
BACKGROUND Stereotactic radiosurgery (SRS) has become a mainstay of treatment for patients with metastatic brain tumors. However, metastatic tumors with a large cystic component often exceed the size limit for safe and effective SRS. In such cases, s
Autor:
Lasse Dührsen, Lucius S. Fekonja, Jan Coburger, Julia Onken, Katharina Faust, Stefanie Ott, Mehmet Salih Tuncer, Melina Engelhardt, Andreas Pfnür, Thomas Picht, Peter Vajkoczy, Anna-Gila Karbe
Publikováno v:
Neuro-Oncology. 23:vi230-vi231
OBJECTIVES Surgical resection of gliomas involving the supplementary motor area (SMA) frequently results in a symptom complex commonly described as „SMA syndrome“, which is characterized by transient contralateral akinesia and mutism. As factors
Autor:
Elke Mayer, Astrid E. Grams, Armin Muigg, Martha Nowosielski, Guenther Stockhammer, Sarah Iglseder, Gabriel Bsteh, Johanna Heugenhauser, Meinhard Nevinny-Stickel
Publikováno v:
Neuro Oncol
BACKGROUND Although there is no proven standard therapy for leptomeningeal metastases (LM), treatment often includes intrathecal chemotherapy combined with whole brain radiation therapy (WBRT). Little is known on the toxicity of such combination ther
Autor:
Vinay K. Puduvalli, Greg Fuller, Sujit S. Prabhu, David I. Sandberg, Rebecca Harrison, Monica Loghin, Amol J. Ghia, Susan L. McGovern, Jeffrey S. Weinberg, Barbara O’Brien, Swapnil Khose, Arnold C. Paulino, Wafik Zaky, Frank Y. Lin, Mary Frances McAleer, John DeGroot, Rituraj Upadhyay, Halyna Pokhylevych, Carlos Kamiya-Matsuoka, Jing Li, Claudio E. Tatsui, Jason M. Johnson, Debra Nana Yeboa, Laurence D. Rhines
Publikováno v:
Neuro Oncol
BACKGROUND Primary spinal high-grade gliomas(S-HGG) are rare, aggressive tumors and radiation therapy(RT) plays a dominant role in the management given their infiltrative nature. We conducted a single-institution retrospective review to study the cli
Autor:
Haisong Liu, May Ly, James J. Evans, Voichita Bar-Ad, Jon Glass, Wenyin Shi, David W. Andrews, Maria Werner-Wasik, Christopher J. Farrell, Ayesha S Ali, Andrew Song, Kevin Judy, Iyad Alnahhas, Inna Chervoneva, L Martinez Nina, Ryan C Miller, Joshua D. Palmer
Publikováno v:
Neuro-Oncology. 23:vi43-vi44
INTRODUCTION Current adjuvant treatment for patients with newly diagnosed glioblastoma includes concurrent chemoradiation and maintenance temozolomide with Tumor Treating Fields (TTFields). We report our clinical trial evaluating feasibility and tole
Autor:
Wade M. Mueller, Savannah Duenweg, John Sherman, Michael Brehler, Fitzgerald Kyereme, Samuel Bobholz, Peter S. LaViolette, Elizabeth J. Cochran, Anjishnu Banerjee, Jennifer Connelly, Allison Lowman
Publikováno v:
Neuro-Oncology. 23:vi108-vi109
Tumor treating fields (TTFields) are thought to disrupt the cell division process in glioma. This study uses autopsy tissue samples from patients recruited for brain donation to determine whether TTFields treatment duration and usage affects cellular
Publikováno v:
Neuro-Oncology. 23:vi229-vi230
Maximizing the extent of resection (EOR) while preserving functional integrity is a mainstay of glioma surgery. Intraoperative MRI (iMRI) helps to augment the EOR. However, in eloquently located gliomas the significance of iMRI is controversial since
Autor:
William F. Elmquist, Ian F. Parney, Terence C. Burns, Andrea Hawkins-Daarud, Pamela R. Jackson, Minjee Kim, Leland S. Hu, Kyle W. Singleton, Timothy J. Kaufmann, Jann N. Sarkaria, Afroz S. Mohammad, Kristin R. Swanson
Publikováno v:
Neuro Oncol
Choosing effective chemotherapies for intravenous delivery to brain tumors is challenging, especially given the protective nature of the blood brain barrier (BBB). Connecting drug distribution to non-invasive, pre-surgical magnetic resonance imaging